BackFrazier Lifesciences Acquisition Overview

Frazier Lifesciences Acquisition Receivables

Frazier Lifesciences Acquisition's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Frazier Lifesciences Acquisition Receivables History

Loading

Frazier Lifesciences Acquisition vs. peers: Receivables Comparison

Loading

Frazier Lifesciences Acquisition Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Frazier Lifesciences Acquisition (FLAC) FAQ

Frazier Lifesciences Acquisition (FLAC) currently reports a receivables of $0 as of September 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Frazier Lifesciences Acquisition's receivables history and peer comparisons.

Frazier Lifesciences Acquisition's receivables changed from $0 to $0 (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Frazier Lifesciences Acquisition reported $0 in receivables as of September 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Frazier Lifesciences Acquisition, and consider following FLAC for alerts when major investors trade the stock.